UBS Group’s Windtree Therapeutics WINT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11 | Sell |
22
-28,743
| -100% | -$14.4K | ﹤0.01% | 8823 |
|
|
2025
Q1 | $36.2K | Buy |
28,765
+27,573
| +2,313% | +$34.7K | ﹤0.01% | 6529 |
|
|
2024
Q4 | $20.8K | Buy |
1,192
+1,184
| +14,800% | +$20.7K | ﹤0.01% | 6614 |
|
|
2024
Q3 | $925 | Buy |
+8
| New | +$925 | ﹤0.01% | 7553 |
|
|
2024
Q2 | – | Hold |
0
| – | -$3 | – | 8197 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$366 | – | 7995 |
|
|
2023
Q4 | $366 | Sell |
1
-6
| -86% | -$2.2K | ﹤0.01% | 7489 |
|
|
2023
Q3 | $5.61K | Buy |
+7
| New | +$5.61K | ﹤0.01% | 6215 |
|
|
2023
Q2 | – | Hold |
0
| – | -$1.78K | – | 7645 |
|
|
2023
Q1 | – | Hold |
0
| – | -$62 | – | 7546 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9256 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$14K | – | 9741 |
|
|
2022
Q2 | $14K | Buy |
+1
| New | +$14K | ﹤0.01% | 6393 |
|
|
2022
Q1 | – | Hold |
0
| – | -$7K | – | 8271 |
|
|
2021
Q4 | – | Hold |
0
| – | -$3K | – | 8047 |
|
|
2021
Q3 | – | Hold |
0
| – | -$19K | – | 7694 |
|
|
2021
Q2 | – | Hold |
0
| – | -$3K | – | 6312 |
|
|
2021
Q1 | – | Hold |
0
| – | -$2K | – | 7495 |
|
|
2020
Q4 | – | Hold |
0
| – | -$11K | – | 7091 |
|
|
2020
Q3 | – | Hold |
0
| – | -$25K | – | 5909 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5564 |
|